Medicare's New Trick: Benchmarking Drugs Against Global Prices
Published Date: 12/23/2025
Proposed Rule
Summary
The GLOBE Model is a new plan to help Medicare pay less for certain medicines by using a global price benchmark. This change affects Medicare patients and drug makers, aiming to save money while keeping care quality high. Comments on this plan are open until February 23, 2026, so everyone has a chance to weigh in before it moves forward.
Analyzed Economic Effects
4 provisions identified: 2 benefits, 1 costs, 1 mixed.
Manufacturers must pay GLOBE rebates based on global prices
CMS proposes mandatory participation for all manufacturers of Part B rebatable drugs that are designated as GLOBE Model drugs; those manufacturers would pay GLOBE Model rebates into the Medicare Part B account when the specified amount exceeds a benchmark based on international drug pricing. CMS states the benchmark-based GLOBE Model rebate would not be less than any rebates owed under the existing Medicare Part B Drug Inflation Rebate Program, and manufacturers may submit a Suggestion of Error only for mathematical errors.
CMS estimates multi-billion dollar Medicare savings
CMS estimates the GLOBE Model would reduce overall Medicare Part B net spending by $11.9 billion over the 7-year model period, including about $8.4 billion in Medicare Part B FFS savings, $7.5 billion in Medicare Advantage savings, and about $4.0 billion in premium offset impacts; CMS also estimates about $1.0 billion in Medicaid savings (roughly $0.7 billion federal and $0.3 billion state). When annualized, CMS estimates approximately $2.3 billion in Medicare Part B FFS savings over the 7-year period.
Selected Medicare patients get lower coinsurance
About 25 percent of traditional Medicare Part B fee-for-service beneficiaries in selected geographic areas would be placed in the GLOBE Model cohort. When those beneficiaries receive an included GLOBE Model drug on an applicable date of service, their coinsurance would be reduced (for example, CMS gives an example where a $100 Medicare allowed amount with a reduced coinsurance of 10 percent results in $10 owed by the beneficiary and $90 paid by Medicare, instead of the usual $20/$80 split).
CMS selects cohort; beneficiaries cannot appeal selection
CMS would select which beneficiaries are in the GLOBE Model cohort (based on a beneficiary's address of record in selected geographic areas) and selection would not be subject to appeal; beneficiaries must have traditional Medicare Part B FFS as their primary payer and must not be enrolled in Medicare Advantage, a section 1876 cost plan, or certain prepayment plans to be eligible for cohort inclusion. Providers and suppliers would continue to buy and bill for GLOBE Model drugs as usual, but providers must reduce beneficiary coinsurance when the GLOBE Model reduced coinsurance applies.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-22792, Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program
Starting in 2029, Medicare will negotiate drug prices to help lower costs for people using Medicare Part D. This new rule, effective December 5, 2026, sets clear policies to make prescription drugs more affordable and fair. If you or a loved one uses Medicare for prescriptions, expect some savings and changes in how drug prices are set.
2026-22750, Calendar Year 2027 Home Health Prospective Payment System (HH PPS) Rate Update; Requirements for the HH Quality Reporting Program and the Expanded HH Value-Based Purchasing Model; Medicare Provider Enrollment, Durable Medical Equipment (DME), and DME, Prosthetics, Orthotics, and Supplies (DMEPOS) Policies
Starting in 2027, Medicare is updating how it pays home health agencies, including new payment rates and rules to make care better and fairer. Home health providers, equipment suppliers, and Medicare enrollees will see changes in payment methods, quality reporting, and equipment rules, with some new deadlines and expanded benefits. These updates aim to improve care quality while keeping payments clear and fair.
2026-22743, Medicare and Medicaid Programs; CY 2027 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program
Starting January 1, 2027, Medicare and Medicaid are updating how doctors and clinics get paid to better match real medical work and new laws. This includes new rules for drug price rebates, sharing savings programs, and payment updates for rural clinics and ambulance services. These changes affect doctors, patients, and healthcare providers, aiming to keep care fair, affordable, and up-to-date.
2026-22739, Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems; and Quality Reporting Programs; including the Hospital Outpatient Quality Reporting Program and Ambulatory Surgical Center Quality Program; Request for Information on Strengthening the Standardization and Comparability of Hospital Price Transparency (HPT) Data; Prior Authorization; Accrediting Organization (AO) Deeming for Emergency Medical Treatment and Labor Act (EMTALA); and Notices of Closure of Teaching Hospitals and Opportunities To Apply for Available Slots
Starting in 2027, Medicare is updating how hospitals and surgery centers get paid for outpatient care and surgeries. These changes affect hospitals, surgery centers, and patients by adjusting payment rates and improving quality reporting. Plus, CMS is asking for ideas to make hospital price info clearer and easier to compare, while also handling rules about emergency care and teaching hospital closures.
2026-22381, Medicare and Medicaid Programs; Organ Procurement Organizations Conditions for Coverage: Revisions to the Conditions for Coverage
This new rule updates how Organ Procurement Organizations (OPOs) operate to help get more life-saving organs to people who need transplants. It changes some definitions, competition rules, and appeal processes to make OPOs work better and be held accountable. These changes start January 4, 2027, and aim to save more lives without adding extra costs.
2026-22194, Medicare Program; CY 2027 Changes to the End-Stage Renal Disease (ESRD) Prospective Payment System, Acute Kidney Injury (AKI) Dialysis Payment, and ESRD Quality Incentive Program
Starting January 1, 2027, Medicare is updating how it pays for kidney dialysis treatments for people with End-Stage Renal Disease (ESRD) and those with Acute Kidney Injury (AKI). These changes include new payment rates and updated quality rules to make sure patients get the best care. If you’re a dialysis provider or patient, expect some shifts in payments and quality standards that aim to improve treatment and support innovation.
Previous / Next Documents
Previous: 2025-23693, Transparency in Coverage
Starting soon, health plans and insurers must share clearer, easier-to-understand price info for medical services. This means better details on what you’ll pay in-network and out-of-network, with more frequent updates and extra info like plan types and provider networks. These changes affect most group and individual health plans and aim to help you shop smarter and save money by December 2026.
Next: 2025-23704, Debt Collection Authorities Under the Debt Collection Improvement Act of 1996
The Treasury is updating rules for the Treasury Offset Program, which helps collect government debts by taking money from payments owed to people who owe the government. These changes make the rules clearer, bring back some flexible options, and add new powers to improve debt collection. If you’re involved with government payments or debts, watch out—comments on these updates are open until February 23, 2026.